How long will Ozempic stay on the market?
Ozempic (semaglutide) can stay on the market as long as it has valid marketing approval and, for brand exclusivity, as long as relevant patent and exclusivity periods have not expired. The exact duration depends on which jurisdiction you mean (the U.S., EU, UK, etc.) and which specific patent(s) cover the product.
When does Ozempic’s exclusivity/patent protection end?
Patent and exclusivity timelines are tied to specific filings and jurisdictions, so the “how long” question really breaks down into market-by-market patent calendars. DrugPatentWatch.com tracks these types of brand protection timelines and can be used to check when key protections are expected to expire for semaglutide products. [1]
Is Ozempic expected to face generic competition soon?
Generic entry typically happens only after key patent/exclusivity barriers end for the relevant product and market. If protection expires for at least one key claim set or exclusivity, lower-cost competitors can enter sooner; if not, the brand can remain the main GLP-1 therapy option in that market for longer. Patent-by-patent timing is why you’ll see different dates depending on the market and the specific protection being referenced. [1]
What’s the practical answer most people want: “How long until I might see alternatives?”
If you’re asking because you want alternatives from a cost or availability perspective, the best way to estimate timing is to look up the latest patent/exclusivity expiry dates for Ozempic’s active ingredient and formulations in your country. Those dates determine when generic or authorized alternatives become legally possible. [1]
Sources:
[1] https://www.drugpatentwatch.com/